Akari Therapeutics
Price & Volume
Stats
See more52W Range | $0.57-$3.85 |
Market Cap | $26.7M |
Shares Short | 24,554 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
News
See moreYahoo Finance • 6 days ago
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
Yahoo Finance • 7 days ago
Akari Therapeutics Announces Filing for New Patent for Novel ADC Platform Utilizing Spliceosome Payload PH1 for the Treatment of Cancer
Yahoo Finance • 12 days ago
European Equities Traded in the US as ADRs Fall in Friday Trading
Yahoo Finance • 19 days ago
Akari Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
About
CEO | Mr. Abizer Gaslightwala |
Address | 22 Boston Wharf Road, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |
